Applied Enterprise Value over EBITDA from 2010 to 2024
| APLT Stock | USD 4.31 0.15 3.36% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (3.64) | Current Value (3.82) | Quarterly Volatility 8.19476952 |
Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
Applied | Enterprise Value over EBITDA |
About Applied Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Applied Therapeutics income statement, its balance sheet, and the statement of cash flows. Applied Therapeutics investors use historical funamental indicators, such as Applied Therapeutics's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may use each financial statement separately, they are all related. The changes in Applied Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Applied Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Applied Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Applied Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Applied Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Pair Trading with Applied Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Applied Stock
| 0.88 | VKTX | Viking Therapeutics Earnings Call Today | PairCorr |
| 0.8 | ELEV | Elevation Oncology Financial Report 20th of May 2024 | PairCorr |
| 0.63 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
Moving against Applied Stock
| 0.44 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Applied Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied Therapeutics to buy it.
The correlation of Applied Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Applied Therapeutics Correlation against competitors. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Applied Stock analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Applied Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.119 | Return On Assets (0.87) | Return On Equity (6.82) |
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.